Transcriptional control and enhancer recruitment in mouse and human intestinal secretory differentiation

小鼠和人类肠道分泌分化中的转录控制和增强子招募

基本信息

  • 批准号:
    10584678
  • 负责人:
  • 金额:
    $ 37.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Intestinal secretory (Sec: goblet (Gob), enteroendocrine (EE), Paneth (Pan), and tuft) cells serve vital digestive, metabolic, barrier, and other physiologic functions. Intestinal stem cells (ISCs) replenish both absorptive and Sec epithelial cells, but the origins of Sec diversity and census are largely unknown. Because it has been difficult to isolate and characterize intermediate precursor cell states, much of the current understanding of the mouse and human Sec lineages rests on mouse genetic studies. On morphologic and functional grounds, the four mature Sec cell types are considered distinct and their origins trace to a common ATOH1-expressing crypt progenitor (Sec-Pro), although some mouse EE and tuft –but not Gob or Pan– cells arise in the absence of this Sec-specifying transcription factor (TF). Cell fates are generally dictated by cell- specific cis-regulatory elements (CREs – mainly enhancers) that drive particular transcriptional programs under the direction of cell-restricted TFs. To understand how primitive Sec-Pro execute subsequent CRE and cell fate decisions, we have developed two parallel and powerful experimental systems: (1) Capture of labeled early mouse Sec derivatives in vivo for deep characterization of gene and enhancer activity at single- cell resolution, and (2) Differentiation of 2D human ISC-like cells in vitro along the full Sec lineage. Both models yield large numbers of multi- and bi-potential precursors, hence allowing original mechanistic insights into the corresponding transcriptional and CRE states. Our three Specific Aims integrate findings from the two parallel models to decipher the epigenetic basis and regulatory TF logic of mouse and human Sec cell differentiation. Aim 1 uses mRNA and open-chromatin profiles of precursor and descendant Sec cells within a differentiation continuum to characterize the salient features of specific intermediate states, map previously unknown TF-driven transitions, distinguish cell-autonomous from -extrinsic factors, and thus derive a unifying model for mammalian Sec lineage diversity. Considered in the light of scattered published findings, our preliminary data suggest that Gob and Pan are not genuinely distinct cell types, but different versions of a versatile Sec end-product where specific local signals act on the same complement of open chromatin to drive Gob or Pan features. Aim 2 applies a suite of in vitro and in vivo experiments to test specific hypotheses that epidermal growth factor (EGF) and especially canonical Wnt signaling favor the Pan state, while bone morphogenetic protein (BMP) signaling drives the Gob state. We will examine how alternative recruitment of Gob- or Pan-selective CREs by specific signaling pathways might underlie these fluid cell states. Aim 3 uses gain- and loss-of-function strategies to address previously challenging questions about TF-driven specification of human Sec, especially EE and tuft, cells. Overall, a particular strength of this proposal is the deeply mechanistic investigation of cell-specific CREs and TFs that together dictate interim and final cell potential in the murine and human Sec lineage.
项目总结 肠道分泌细胞(SEC:杯状细胞(Gob)、内分泌细胞(EE)、内分泌细胞(Paneth)和簇状细胞(Tuft)) 消化、代谢、屏障和其他生理功能。肠道干细胞(ISCs)补充了这两种细胞 吸收细胞和SEC上皮细胞,但SEC多样性和普查的起源在很大程度上是未知的。因为 分离和表征中间前体细胞状态一直很困难,目前大部分 对小鼠和人类SEC血统的了解取决于对小鼠的遗传学研究。浅谈形态和 功能基础,四种成熟的SEC细胞类型被认为是不同的,它们的起源可以追溯到共同的 Atoh1表达的隐窝祖细胞(SEC-Pro),虽然有些小鼠的EE和TUFT-但不是Gob或泛细胞 在缺少SEC特异性转录因子(Tf)的情况下产生。细胞的命运通常由细胞决定- 驱动特定转录程序的特定顺式调控元件(CRE-主要是增强子) 在细胞限制性因子的指导下。了解原语SEC-Pro如何执行后续的CRE 和细胞命运决定,我们开发了两个并行和强大的实验系统:(1)捕获 体内标记的早期小鼠SEC衍生物用于深入表征基因和单个... 细胞分辨率,以及(2)2D人类ISC样细胞在体外沿着完整的SEC谱系分化。两者都有 模型产生了大量的多势和双势前兆,因此允许原创的机械洞察力 进入相应的转录和Cre状态。我们的三个具体目标综合了来自 破译人和鼠SEC细胞表观遗传学基础和调控转铁蛋白逻辑的两个平行模型 差异化。AIM 1使用前体和子代SEC细胞的mRNA和开放染色质图谱 用于描述特定中间状态的显著特征的微分连续体,先前映射 未知的TF驱动的转变,区分细胞自主和外部因素,从而得出一个统一的 哺乳动物SEC血统多样性的模型。考虑到零星发表的研究结果,我们的 初步数据表明,Gob和潘并不是真正不同的细胞类型,而是不同版本的 多功能SEC最终产物,其中特定的局部信号作用于相同的开放染色质补充,以 驱动器井口或平移功能。目的2应用一套体外和体内实验来检验特定的假说 表皮生长因子(EGF),特别是典型的Wnt信号有利于泛态,而骨骼 形态发生蛋白(BMP)信号驱动Gob状态。我们会研究如何以其他方式招聘 特定信号通路的GOB或泛选择性Cre可能是这些流体细胞状态的基础。AIM 3用途 功能增益型和功能损失型策略,以解决先前关于TF驱动的挑战性问题 人体SEC细胞,特别是EE和TUFT细胞的规格。总体而言,这项建议的一个特别优点是 对共同决定中间和最终细胞的特定细胞CRE和TF的深入机械研究 在小鼠和人类SEC血统中的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ramesh A Shivdasani其他文献

Ramesh A Shivdasani的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ramesh A Shivdasani', 18)}}的其他基金

Development and vascularity of intestinal mesenchyme
肠间质的发育和血管分布
  • 批准号:
    10735493
  • 财政年份:
    2019
  • 资助金额:
    $ 37.26万
  • 项目类别:
Cellular and molecular characterization of the digestive tract sub-epithelium
消化道上皮下层的细胞和分子特征
  • 批准号:
    9764595
  • 财政年份:
    2019
  • 资助金额:
    $ 37.26万
  • 项目类别:
Cellular and molecular characterization of the digestive tract sub-epithelium
消化道上皮下层的细胞和分子特征
  • 批准号:
    10381661
  • 财政年份:
    2019
  • 资助金额:
    $ 37.26万
  • 项目类别:
Chromatin and transcriptional control of LGR5+ crypt base stem cells
LGR5 隐窝基底干细胞的染色质和转录控制
  • 批准号:
    9135746
  • 财政年份:
    2014
  • 资助金额:
    $ 37.26万
  • 项目类别:
Anatomic and functional characterization of the intestinal crypt-villus niche
肠隐窝绒毛生态位的解剖和功能特征
  • 批准号:
    10237318
  • 财政年份:
    2014
  • 资助金额:
    $ 37.26万
  • 项目类别:
Anatomic and functional characterization of the intestinal crypt-villus niche
肠隐窝绒毛生态位的解剖和功能特征
  • 批准号:
    10469333
  • 财政年份:
    2014
  • 资助金额:
    $ 37.26万
  • 项目类别:
Chromatin and transcriptional control of LGR5+ crypt base stem cells
LGR5 隐窝基底干细胞的染色质和转录控制
  • 批准号:
    9333357
  • 财政年份:
    2014
  • 资助金额:
    $ 37.26万
  • 项目类别:
Chromatin and transcriptional control of LGR5+ crypt base stem cells
LGR5 隐窝基底干细胞的染色质和转录控制
  • 批准号:
    9130871
  • 财政年份:
    2014
  • 资助金额:
    $ 37.26万
  • 项目类别:
Regulation of intestinal genes by CDX2 and other tissue-restricted transcription factors
CDX2 和其他组织限制性转录因子对肠道基因的调节
  • 批准号:
    10222655
  • 财政年份:
    2010
  • 资助金额:
    $ 37.26万
  • 项目类别:
Analysis of intestinal genes regulated by the transcription factor CDX2
转录因子CDX2调控的肠道基因分析
  • 批准号:
    7918716
  • 财政年份:
    2010
  • 资助金额:
    $ 37.26万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.26万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了